Eaton to Showcase New Filtration Solutions for Liquids at ACHEMA 2024
Eaton has announced that the company will be exhibiting numerous new filtration solutions for the Industrial Processing, Life Sciences, and Hydraulic Filtration segments.
Global Pharma | 09/04/2024 | By Aishwarya | 642
Merck India Welcomes Dhananjay Singh as New MD of Life Science in India
Merck, a science and technology company, has appointed Dhananjay Singh as the Managing Director of Merck Life Science in India.
Global Pharma | 09/04/2024 | By Aishwarya | 935
Pharming Completes Enrollment in Pediatric Clinical Trial of leniolisib
Pharming Group has recently completed patient enrollment in its Phase III clinical trial (NCT05438407) evaluating the investigational drug leniolisib.
Global Pharma | 09/04/2024 | By Aishwarya | 557
Indigenously Developed CAR T-Cell Therapy Launched for Cancer Treatment in India
President Droupadi Murmu has rolled out India’s first indigenously-developed CAR T-cell therapy for the treatment of cancer.
Global Pharma | 09/04/2024 | By Aishwarya | 1183
Lupin Gains Approval from FDA for Valbenazine Capsules
Lupin Ltd. has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Valbenazine Capsules.
Global Pharma | 09/04/2024 | By Aishwarya | 1057
Rebound Medical Receives Growth Equity Investment from Castleford Capital
Rebound provides durable medical equipment to patients recovering from orthopedic and vascular surgical procedures.
Global Pharma | 08/04/2024 | By Manvi | 489
Clarius and ThinkSono Introduce New AI-Guided Ultrasound System Enabling Rapid Assessments of DVTs
DVT is a blood clot found commonly in the leg and is a leading cause of preventable hospital death in Europe and the United States.
Global Pharma | 08/04/2024 | By Manvi | 708
Gericke Rolls Out AirCIP System for Horizontal Shaft Mixers
Gericke has introduced its innovative AirCIP system that enables complete discharge and cleaning of horizontal shaft mixers without the need for bomb doors or manual intervention.
<br />
Global Pharma | 08/04/2024 | By Aishwarya | 333
Piramal Alternatives Announces Investment of INR 110 Crore in Biodeal
Piramal Alternatives has made a significant investment of INR 110 Crore in Biodeal Pharmaceuticals Ltd., a leading contract development and manufacturing company, facilitated through convertible instruments from its Performing Credit Fund.
Global Pharma | 08/04/2024 | By Aishwarya | 711
Freudenberg Group to Expand in India with INR 350 Crore Investment
Freudenberg Group, a global technology conglomerate, has reported record growth in revenues and operating profits for the financial year 2023.
Global Pharma | 08/04/2024 | By Aishwarya | 1105
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy